Cybersecurity in a Connected Pharmaceutical Environment:

Suanfarma Case Study

As pharmaceutical organizations continue to digitalize their operations, cybersecurity is becoming increasingly critical to ensuring business continuity, regulatory compliance, and the secure management of sensitive information. The growing adoption of connected technologies across manufacturing, laboratory, and supply chain environments is creating new opportunities, but also introducing new cyber risks.

Suanfarma is a B2B life sciences company dedicated to health and innovation. The company develops, manufactures, and distributes Active Pharmaceutical Ingredients (APIs), supporting customers across the global pharmaceutical value chain.

Operating in a highly regulated environment, Suanfarma faces cybersecurity challenges that extend beyond traditional IT systems. As digitalization and connectivity continue to increase, ensuring the resilience of manufacturing operations, laboratory systems, and connected equipment becomes increasingly important. At the same time, Suanfarma must manage cybersecurity risks associated with a complex ecosystem of third-party providers and partners that support its operations.

To address these challenges, Suanfarma partnered with Bureau Veritas Cybersecurity to better understand its cybersecurity maturity and identify opportunities for improvement. Through a combination of cybersecurity assessments, strategic advisory services, penetration testing, and cybersecurity awareness initiatives, the objective was to establish a structured roadmap for strengthening cybersecurity across the organization.

A key focus was understanding how cybersecurity risks could impact operational environments where availability, reliability, and continuity are critical. Unlike traditional IT systems, operational technologies and connected industrial environments were not always designed with cybersecurity as a primary requirement, requiring dedicated risk management and protection measures. At the same time, evolving cybersecurity regulations are driving additional controls, continuous monitoring, and regular risk assessments across the pharmaceutical sector. Rather than viewing these requirements as constraints, Suanfarma sees them as an opportunity to strengthen its cybersecurity posture and organizational resilience.

Working closely together, Bureau Veritas Cybersecurity helped Suanfarma establish a clearer understanding of its cybersecurity maturity and define a practical roadmap for continuous improvement. Through technical assessments, strategic advisory, and training initiatives, the collaboration strengthened cybersecurity awareness, supported regulatory readiness, and embedded cybersecurity across the organization. As pharmaceutical operations become increasingly connected, cybersecurity plays a critical role in ensuring operational continuity, managing supply chain risks, and supporting long-term business resilience.